View Clinical Trial (Medical Research Study)
A Pilot Study of a Dendritic Cell Vaccine in HIV-1 Infected Subjects - NCT00833781-02114(Clinical Trial 268934)
ClinicalConnection.com has recently undergone an update and this page may no longer be up-to-date. Please Search For Clinical Trials to view the most current clinical trials listings.
| City: |
|
Boston |
|
State:
|
|
MA |
| Zip Code: |
|
02114 |
| Conditions: |
|
HIV-1 Infection - HIV Infections |
| Purpose: |
|
The purpose of the study is to find out whether an experimental autologous dendritic cell
vaccine is safe, well tolerated, and whether it can strengthen the immune system's response
to HIV.
|
| Study summary: |
|
|
| Criteria: |
|
Inclusion Criteria:
- HIV-1 positive
- CD4+ T Cell count >200
- Undetectable HIV viral load for 6 months prior to screening
- On antiretroviral treatment for 12 months prior to screening
Exclusion Criteria:
- Hepatitis C positive
- Detectable HIV viral load within 6 months prior to study entry
- Females who are pregnant or nursing |
|
|
|
| Study is available at: |
|
Infectious Disease Unit; Massachusetts General Hospital
Boston, MA 02114
United States
Primary Contact:
Douglas Kwon, MD, PhD
Email: dkwon@partners.org
Phone: 617-726-4748 |
|
|
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
|
| Trials Alerts: |
|
If you would like to be
notified of new clinical trials as they become available please
register for a free account.
|
|
| Data Source: |
|
ClinicalTrials.gov |
| Date Processed: |
|
March 23, 2011 |
Modifications to
this listing: |
|
Only selected fields are shown, please use the link
above to view all information about this clinical trial. |
|
|
|
|
|
|
|
|